News

According to the agreement, International Medical Systems (IMS) will have the exclusive right to sell the Lapex 2000 LipoLaser in the following countries during the first phase of

The underwriters have a 30-day option to purchase up to an additional 825,000 shares of common stock. Sequenom expects the net proceeds from the offering to be used

Famotidine Injection is indicated for the short term treatment of duodenal and gastric ulcers and gastroesophageal reflux disease. Famotidine Injection is therapeutically equivalent to the brand product Pepcid

The clinical data from this study will form the basis of a supplemental new drug application (sNDA) to the FDA for Vivitrol for the treatment of opioid dependence,

The test detects the presence of Heparin/PF-4 antibody, which is associated with patients at risk for heparin-induced thrombocytopenia (HIT), and is rapidly becoming a standard of care in

The RAMP cardiovascular product line includes Troponin I, CK-MB, Myoglobin and NT-proBNP Tests. The company is awaiting FDA 510(k) clearance before the NT-proBNP Test can be sold in

The TLN-232 trial is the second Phase II study to be initiated this year from Thallion’s oncology pipeline. The multi-centre open label Phase II trial will enroll up

The biomarkers were discovered through the use of Compugen’s Nucleic Acid Testing (NAT) discovery platform. A key component of the discovery effort was the integration of proprietary expression

The trial results indicated that the endovascular aortic repair (EVAR) procedure, using the Cook Zenith, is a safe and effective alternative to open surgical repair for the treatment